FdaNdcDirectoryPulse / compare
BRYTLY vs good sense acid reducer: FdaNdcDirectoryPulse comparison
BRYTLY (2026-10-16) and good sense acid reducer (2026-10-15) are peer FdaNdcDirectoryPulse records.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does BRYTLY compare to good sense acid reducer?
| Field | BRYTLY | good sense acid reducer |
|---|---|---|
| Product | BRYTLY | good sense acid reducer |
| Generic name | Apraclonidine Hydrochloride | Cimetidine |
| NDC | 0065-8596 | 0113-7099 |
| Labeler | Alcon Laboratories, Inc. | L. Perrigo Company |
| Product type | HUMAN OTC DRUG | HUMAN OTC DRUG |
| Approval pathway | NDA | ANDA |
| Application number | NDA220341 | ANDA075285 |
| Dosage form | SOLUTION/ DROPS | TABLET, FILM COATED |
| Route | OPHTHALMIC | ORAL |
| Active ingredients | APRACLONIDINE HYDROCHLORIDE 1.25 mg/mL | CIMETIDINE 200 mg/1 |
| Marketing start | 2026-10-16 | 2026-10-15 |
| Package configurations | 3 | 1 |
| Launch Signal Score | 45/100 | 40/100 |
| Peer rank and all 500 records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: BRYTLY · good sense acid reducer
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.